171 related articles for article (PubMed ID: 26417339)
1. Probing the origins of aromatase inhibitory activity of disubstituted coumarins via QSAR and molecular docking.
Worachartcheewan A; Suvannang N; Prachayasittikul S; Prachayasittikul V; Nantasenamat C
EXCLI J; 2014; 13():1259-74. PubMed ID: 26417339
[TBL] [Abstract][Full Text] [Related]
2. Insights into antioxidant activity of 1-adamantylthiopyridine analogs using multiple linear regression.
Worachartcheewan A; Nantasenamat C; Owasirikul W; Monnor T; Naruepantawart O; Janyapaisarn S; Prachayasittikul S; Prachayasittikul V
Eur J Med Chem; 2014 Feb; 73():258-64. PubMed ID: 24412501
[TBL] [Abstract][Full Text] [Related]
3. Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking.
Worachartcheewan A; Songtawee N; Siriwong S; Prachayasittikul S; Nantasenamat C; Prachayasittikul V
Med Chem; 2019; 15(4):328-340. PubMed ID: 30251609
[TBL] [Abstract][Full Text] [Related]
4. QSAR modeling of aromatase inhibitory activity of 1-substituted 1,2,3-triazole analogs of letrozole.
Nantasenamat C; Worachartcheewan A; Prachayasittikul S; Isarankura-Na-Ayudhya C; Prachayasittikul V
Eur J Med Chem; 2013 Nov; 69():99-114. PubMed ID: 24012714
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives.
Roy PP; Roy K
J Pharm Pharmacol; 2010 Dec; 62(12):1717-28. PubMed ID: 21054398
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling evaluation of non-steroidal aromatase inhibitors.
Narayana BL; Pran Kishore D; Balakumar C; Rao KV; Kaur R; Rao AR; Murthy JN; Ravikumar M
Chem Biol Drug Des; 2012 May; 79(5):674-82. PubMed ID: 22129073
[TBL] [Abstract][Full Text] [Related]
7. 2D-QSAR and docking study of a series of coumarin derivatives as inhibitors of CDK (anticancer activity) with an application of the molecular docking method.
Kasmi R; Hadaji E; Chedadi O; El Aissouq A; Bouachrine M; Ouammou A
Heliyon; 2020 Aug; 6(8):e04514. PubMed ID: 32817887
[TBL] [Abstract][Full Text] [Related]
8. Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors.
Roy PP; Roy K
J Mol Model; 2010 Oct; 16(10):1597-616. PubMed ID: 20195667
[TBL] [Abstract][Full Text] [Related]
9. QSAR models for antioxidant activity of new coumarin derivatives.
Erzincan P; Saçan MT; Yüce-Dursun B; Danış Ö; Demir S; Erdem SS; Ogan A
SAR QSAR Environ Res; 2015; 26(7-9):721-37. PubMed ID: 26470736
[TBL] [Abstract][Full Text] [Related]
10. Origin of aromatase inhibitory activity via proteochemometric modeling.
Simeon S; Spjuth O; Lapins M; Nabu S; Anuwongcharoen N; Prachayasittikul V; Wikberg JE; Nantasenamat C
PeerJ; 2016; 4():e1979. PubMed ID: 27190705
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitory activity of 1,4-naphthoquinone derivatives and QSAR study.
Prachayasittikul V; Pingaew R; Worachartcheewan A; Sitthimonchai S; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
EXCLI J; 2017; 16():714-726. PubMed ID: 28827987
[TBL] [Abstract][Full Text] [Related]
12. Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer.
Awasthi M; Singh S; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2015; 33(4):804-19. PubMed ID: 24702656
[TBL] [Abstract][Full Text] [Related]
13. A study on quantitative structure-activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold.
Abbasi M; Ramezani F; Elyasi M; Sadeghi-Aliabadi H; Amanlou M
Daru; 2015 Apr; 23(1):29. PubMed ID: 25925871
[TBL] [Abstract][Full Text] [Related]
14. QSAR and molecular docking studies of 1,3-dioxoisoindoline-4-aminoquinolines as potent antiplasmodium hybrid compounds.
Mahmud AW; Shallangwa GA; Uzairu A
Heliyon; 2020 Mar; 6(3):e03449. PubMed ID: 32154412
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Structure-Activity Relationship (QSAR) Modelling of Indomethacin Derivatives Using Regression Analysis.
Shukla N; Sharma B
Curr Med Chem; 2023 Oct; ():. PubMed ID: 37818563
[TBL] [Abstract][Full Text] [Related]
16. DFT-Based QSAR Modelling of Inhibitory Activity of Coumarins and Sulfocoumarins on Carbonic Anhydrase (CA) Isoforms (CA I and CA II).
Eroglu E
Curr Comput Aided Drug Des; 2019; 15(3):243-251. PubMed ID: 30526468
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors.
Leonetti F; Favia A; Rao A; Aliano R; Paluszcak A; Hartmann RW; Carotti A
J Med Chem; 2004 Dec; 47(27):6792-803. PubMed ID: 15615528
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase.
Stefanachi A; Favia AD; Nicolotti O; Leonetti F; Pisani L; Catto M; Zimmer C; Hartmann RW; Carotti A
J Med Chem; 2011 Mar; 54(6):1613-25. PubMed ID: 21341743
[TBL] [Abstract][Full Text] [Related]
19. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
[TBL] [Abstract][Full Text] [Related]
20. Rational design of novel coumarins: A potential trend for antioxidants in cosmetics.
Worachartcheewan A; Prachayasittikul V; Prachayasittikul S; Tantivit V; Yeeyahya C; Prachayasittikul V
EXCLI J; 2020; 19():209-226. PubMed ID: 32256267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
